Diffusion tensor imaging‐based machine learning for IDH wild‐type glioblastoma stratification to reveal the biological underpinning of radiomic features
CNS Neuroscience & Therapeutics · 2023
DOI: 10.1111/cns.14263 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Zilong Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
This study addresses the lack of systematic investigation into the prognostic value of hand‐crafted radiomic features derived from diffusion tensor imaging (DTI) in isocitrate dehydrogenase (IDH) wild‐type glioblastoma (GBM), as well as the limited understanding of the biological interpretation of individual DTI radiomic features and metrics.
Aims
To develop and validate a DTI‐based radiomic model for predicting prognosis in patients with IDH wild‐type GBM and reveal the biological underpinning of individual DTI radiomic features and metrics.
Results
The DTI‐based radiomic signature was an independent prognostic factor ( p < 0.001). Incorporating the radiomic signature into a clinical model resulted in a radiomic‐clinical nomogram that predicted survival better than either the radiomic model or clinical model alone, with a better calibration and classification accuracy. Four categories of pathways (synapse, proliferation, DNA damage response, and complex cellular functions) were significantly correlated with the DTI‐based radiomic features and DTI metrics.
Conclusion
The prognostic radiomic features derived from DTI are driven by distinct pathways involved in synapse, proliferation, DNA damage response, and complex cellular functions of GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Zhenyu Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Z., Guan, F., Duan, W., Guo, Y., Pei, D., Qiu, Y., Wang, M., Xing, A., Liu, Z., Yu, B., Zheng, H., Liu, X., Yan, D., Ji, Y., Cheng, J., Yan, J., & Zhang, Z. (2023). Diffusion tensor imaging‐based machine learning for IDH wild‐type glioblastoma stratification to reveal the biological underpinning of radiomic features. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14263
Vancouver
Wang Z, Guan F, Duan W, Guo Y, Pei D, Qiu Y, et al. Diffusion tensor imaging‐based machine learning for IDH wild‐type glioblastoma stratification to reveal the biological underpinning of radiomic features. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14263
BibTeX
@article{Wang2023,
author = {Wang, Zilong and Guan, Fangzhan and Duan, Wenchao and Guo, Yu and Pei, Dongling and Qiu, Yuning and Wang, Minkai and Xing, Aoqi and Liu, Zhongyi and Yu, Bin and Zheng, Hongwei and Liu, Xianzhi and Yan, Dongming and Ji, Yuchen and Cheng, Jingliang and Yan, Jing and Zhang, Zhenyu},
title = {Diffusion tensor imaging‐based machine learning for IDH wild‐type glioblastoma stratification to reveal the biological underpinning of radiomic features},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
doi = {10.1111/cns.14263}
}
EUVIMED